scispace - formally typeset
D

Dana A. Leonard

Researcher at Brigham and Women's Hospital

Publications -  17
Citations -  331

Dana A. Leonard is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Odds ratio & Retrospective cohort study. The author has an hindex of 8, co-authored 17 publications receiving 256 citations.

Papers
More filters
Journal ArticleDOI

Modeling 1-year survival after surgery on the metastatic spine

TL;DR: This study demonstrates the importance of including factors related to the overall health of a patient, in addition to parameters surrounding their cancer diagnosis, to better prognosticate survival.
Journal ArticleDOI

Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS).

TL;DR: This study demonstrates the clinical accuracy of the NESMS score for predicting short-term major morbidity and mortality following metastatic spinal surgery in an independent cohort of patients collected from centers across the United States.
Journal ArticleDOI

Predictors of 30- and 90-Day Survival Following Surgical Intervention for Spinal Metastases: A Prognostic Study Conducted at Four Academic Centers.

TL;DR: Improved nutritional status and ambulatory function may enhance postoperative survival among individuals who undergo surgical intervention for spinal metastases, and this effort is one of the first to identify predictors of acute post operative survival in a large series of patients treated for spinal cancer.
Journal ArticleDOI

The effect of short (2-weeks) versus long (6-weeks) post-operative restrictions following lumbar discectomy: a prospective randomized control trial.

TL;DR: The results of this randomized trial suggest equivalent clinical outcomes irrespective of the length of post-operative restriction, if patients are deemed at low risk for a reherniation event they may be confidence that early return to activity at 2 weeks will not compromise outcomes and may not adversely impact the risk of rehernation.